HEMATOLOGY AND ONCOLOGY CLINICS OF NORTH AMERICA
HEMATOLOGY AND ONCOLOGY CLINICS OF NORTH AMERICA...
IN THIS VOLUME (22) OF HEMATOLOGY AND ONCOLOGY CLINICS THE MAIN THING IS ALL ABOUT THE ANTIPHOSPHOLIPID SYNDROME.THE EVERY THING THAT RESEMBLES WITH ANTIPHOSPHOLIPID SYNDROME ARE INCLUDE IN THIS BOOK.
LIKE..
1. CLINICAL SPECTRUM OF ANTIPHOSPHOLIPID SYNDROM.
2. THE RELATIONSHIP BETWEEN ANTIPHOSPHOLIPID SYNDROME AND HEPARIN INDUCED THROMBOCYTOPENIA.
3. LABORATORY EVALUATION OF THE ANTI PHOSPHOLIPID SYNDROME.
4. ANTIPHOSPHOLIPID ANTIBODY SYNDROME AND AUTOIMMUNE DISEASES.
AND ALSO THE BRIEFE DISCUTION OF,
ANTIPHOSPHOLIPID SYNDROME IN,
PREGNANCY ,MALIGNANCY , AND INFECTIOUS DISEASES.
AFTER THE READING OF THIS BOOK YOU MUST UNDERSTAND ABOUT THE ALL TOPICS MENTIONED ABOVE AND ALSO MUCH MORE IN THIS BOOK.
THIS ISSUE OF HEMATOLOGY AND ONCOLOGY CLINICS OF NORTH AMERICAIS DEDICATED TO THE TOPIC OF ANTI PHOSPHOLIPID SYNDROME. THE ANT PHOSPHOLIPID SYNDROME IS THE MOST COMMON OF THE ACQUIRED THROMBOPHILIAS BUT REMAIN UN CLEAR AND CONFUSING T MOST CLINICIANS IN GENERAL THESE DISORDERS COMMONLY LEAD TO ARTERIAL AND VENOUS THROMBOSIS AND OTHER SERIOUS CLINICAL SEQUELAE , BUT MANY PHYSICIANS FORGET TO CONSIDER TESTING FOR ANTI PHOSPHOLIPID SYNDROME WHEN FACED WITH THESE EVENTS. INDEED MANY DO NOT RECOGNIZE THE DIFFERENT ANTIPHOSPHOLIPID ANTIBODIES THAT MAY BE ASSOCIATED WITH THESE EVENTS. THESE ANTI BODIES INCLUDE LUPUS ANTICOAGULANTS ANTI CARDIOLIPIN ANTIBODIES ,BETA 2 GLYCOPROTEINS, AND ANTIPHOSPHOLIPID ANTIBODY SUBGROUPS INCLUDING ANTIPHOSPHATIDYLSERINE , ANTIPHOSPHATIDYLCEROL, ANTI PHOSPHATIDYLCHOLINE, ANTIPHOSPHATIDIC ACID AND AXAGONAL PHOSPHOLIPID . THESE ANTIPHOSPHOLIPID ANTIBODIES LEADS TO THROMBOTIC ,THROMBOEMBOLIC , AND OTHER CATAS TROPHIC EVENTS IN A VIDE VARIETY OF MEDICAL AND SURGICAL SETTINGS. THUS THIS ISUE IS WRITTEN BY EXPERTS IN THE VARIOUS SPECIALTIES IN WHICH ANTIPHOSPHOLIPID SYNDROMES ARE MOST COMMONLY SEEN IN ADDITION SECTIONS ARE DEDICATED TO LABORATORY DIAGNOSTIC FEATURES AND AVAILABLE TESTS, PATHOPHYSIOLOGY ,AND CONTROVERSIES.